UnitedHealth Group Incorporated (NYSE:UNH) Shares Sold by Farallon Capital Management LLC

Farallon Capital Management LLC lessened its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 4.9% in the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 1,618,200 shares of the healthcare conglomerate’s stock after selling 83,210 shares during the period. UnitedHealth Group accounts for approximately 3.9% of Farallon Capital Management LLC’s investment portfolio, making the stock its biggest position. Farallon Capital Management LLC owned approximately 0.18% of UnitedHealth Group worth $824,085,000 at the end of the most recent reporting period.

Several other institutional investors also recently bought and sold shares of UNH. Swedbank AB purchased a new position in shares of UnitedHealth Group in the first quarter worth about $1,117,462,000. Mitsubishi UFJ Asset Management Co. Ltd. boosted its holdings in shares of UnitedHealth Group by 107.8% during the 1st quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 2,306,729 shares of the healthcare conglomerate’s stock worth $1,141,113,000 after purchasing an additional 1,196,758 shares during the last quarter. Dimensional Fund Advisors LP increased its holdings in shares of UnitedHealth Group by 30.0% in the second quarter. Dimensional Fund Advisors LP now owns 3,816,254 shares of the healthcare conglomerate’s stock valued at $1,942,956,000 after purchasing an additional 880,183 shares during the last quarter. Baillie Gifford & Co. boosted its stake in UnitedHealth Group by 1,125.4% during the second quarter. Baillie Gifford & Co. now owns 894,006 shares of the healthcare conglomerate’s stock worth $455,281,000 after buying an additional 821,050 shares during the last quarter. Finally, Public Employees Retirement Association of Colorado increased its stake in shares of UnitedHealth Group by 3,464.9% in the 4th quarter. Public Employees Retirement Association of Colorado now owns 825,311 shares of the healthcare conglomerate’s stock worth $434,501,000 after acquiring an additional 802,160 shares during the last quarter. 87.86% of the stock is currently owned by institutional investors and hedge funds.

Insider Transactions at UnitedHealth Group

In other UnitedHealth Group news, CAO Thomas E. Roos sold 2,851 shares of the stock in a transaction that occurred on Wednesday, July 17th. The shares were sold at an average price of $569.88, for a total value of $1,624,727.88. Following the transaction, the chief accounting officer now directly owns 29,501 shares in the company, valued at $16,812,029.88. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. In other UnitedHealth Group news, CAO Thomas E. Roos sold 2,851 shares of the firm’s stock in a transaction dated Wednesday, July 17th. The stock was sold at an average price of $569.88, for a total transaction of $1,624,727.88. Following the transaction, the chief accounting officer now owns 29,501 shares of the company’s stock, valued at $16,812,029.88. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, EVP Erin Mcsweeney sold 1,500 shares of the company’s stock in a transaction dated Thursday, July 18th. The shares were sold at an average price of $579.03, for a total value of $868,545.00. Following the completion of the sale, the executive vice president now directly owns 7,785 shares of the company’s stock, valued at $4,507,748.55. The disclosure for this sale can be found here. Corporate insiders own 0.33% of the company’s stock.

UnitedHealth Group Trading Down 0.2 %

UNH opened at $573.67 on Tuesday. The company has a debt-to-equity ratio of 0.67, a current ratio of 0.88 and a quick ratio of 0.88. The stock has a market capitalization of $528.00 billion, a price-to-earnings ratio of 35.07, a PEG ratio of 1.64 and a beta of 0.58. The business has a fifty day moving average price of $578.27 and a 200 day moving average price of $521.81. UnitedHealth Group Incorporated has a 12 month low of $436.38 and a 12 month high of $607.94.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Tuesday, July 16th. The healthcare conglomerate reported $6.80 earnings per share for the quarter, beating the consensus estimate of $6.66 by $0.14. UnitedHealth Group had a net margin of 3.66% and a return on equity of 26.55%. The firm had revenue of $98.86 billion for the quarter, compared to analysts’ expectations of $98.73 billion. During the same quarter last year, the company earned $6.14 earnings per share. The firm’s revenue was up 6.4% compared to the same quarter last year. Sell-side analysts expect that UnitedHealth Group Incorporated will post 27.69 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 24th. Stockholders of record on Monday, September 16th will be given a dividend of $2.10 per share. The ex-dividend date of this dividend is Monday, September 16th. This represents a $8.40 annualized dividend and a dividend yield of 1.46%. UnitedHealth Group’s dividend payout ratio is currently 51.34%.

Wall Street Analysts Forecast Growth

UNH has been the subject of several recent analyst reports. UBS Group raised their price objective on shares of UnitedHealth Group from $640.00 to $680.00 and gave the stock a “buy” rating in a research report on Thursday, July 18th. Robert W. Baird lifted their price target on shares of UnitedHealth Group from $597.00 to $640.00 and gave the company an “outperform” rating in a research report on Wednesday, July 17th. Cantor Fitzgerald reissued an “overweight” rating and set a $591.00 target price on shares of UnitedHealth Group in a research note on Monday, September 16th. Royal Bank of Canada upped their price target on UnitedHealth Group from $555.00 to $615.00 and gave the company an “outperform” rating in a research note on Wednesday, July 17th. Finally, Wells Fargo & Company boosted their price objective on shares of UnitedHealth Group from $525.00 to $630.00 and gave the company an “overweight” rating in a report on Wednesday, July 17th. One investment analyst has rated the stock with a hold rating, nineteen have given a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Buy” and an average price target of $614.17.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.